Surgery for a Post-Chemotherapy Residual Mass in Seminoma

Management of residual mass in advanced seminoma: results and recommendations from the Memorial Sloan-Kettering Cancer Center.

Heide S. Puc, R T Heelan, Madhu Mazumdar et al. · Journal of Clinical Oncology · 1996 · 197 citations

Medicine, Oncology, Surgery +16

High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: treatment results and prognostic factors for survival and toxicity.

Robert J. Motzer, Madhu Mazumdar, George J. Bosl et al. · Journal of Clinical Oncology · 1996 · 172 citations

Medicine, Oncology, Pharmacology +16

Advanced seminoma: treatment results, survival, and prognostic factors in 142 patients.

Peter Mencel, Robert J. Motzer, Madhu Mazumdar et al. · Journal of Clinical Oncology · 1994 · 163 citations

Medicine, Oncology, Pharmacology +14

Advanced seminoma: Treatment with cis-platinum-based combination chemotherapy or carboplatin (JM8)

Michael Peckham, A. Horwich, W. F. HENDRY · British Journal of Cancer · 1985 · 143 citations · Full text

Medicine, Oncology, Pharmacology +12

Residual mass: an indication for further therapy in patients with advanced seminoma following systemic chemotherapy.

Robert J. Motzer, George J. Bosl, R T Heelan et al. · Journal of Clinical Oncology · 1987 · 140 citations

Medicine, Oncology, Surgery +12